Introduction
Inhalation studies with mice hold the promise of better understanding the effects of air pollutants on compromised human populations. However, little is known about the factors that will influence dose delivery into the lungs of murine models during an inhalation study. Among the important factors are the respiratory tract anatomy, lung physiology, and particle clearance characteristics. Morphometric studies using mice are rare, but they have found significant differences in the airway morphometry of two murine strains with different genetic backgrounds (Oldham et al., 1994; Oldham and Robinson, 2007) . Relevant differences in respiratory physiology have also been reported for different mouse strains and sexes (Tankersley et al., 1994; Reinhard et al., 2002; Flandre et al., 2003) . In addition, structural and physiological alterations in mouse models of susceptibility as well as in genetically engineered mice may significantly influence inhaled particle deposition (Mall, 2008) . These differences have implications to the dose delivered and the biological outcomes of inhalation studies. Therefore, the objective of this paper is to review the current state of knowledge regarding inhalation dosimetry for mice. Information was obtained from the scientific literature (e.g. using NCBI PubMed and ISI Web of Knowledge) as well as data obtained in our laboratory.
Dosimetry considerations
A fundamental requirement in a toxicology study is that the dose delivered be known. However in inhalation toxicology, the dose is often expressed in terms of exposure due to difficulties in measuring the actual inhaled deposition dose during an experiment. Therefore, inhaled particle doses must often have to be estimated using mathematical relationships in order to interpret experimental results. Dosimetry techniques can establish the relationship between exposure and the doses delivered to and retained by target sites. Deposition, clearance, translocation, and retention comprise the essential elements of dosimetry (US EPA, 2009).
The initial aerosol deposition dose for inhaled particles of a distinct size can be defined as the product of the aerosol concentration in the breathing zone, the exposure duration, the subject's ventilation rate, the sampling efficiency or inhalability, and the deposition efficiency. This dose represents the total initial aerosol dose delivered and deposited in the respiratory tract since particle clearance and sites of local deposition within the respiratory tract are not included. The initial inhaled dose is often normalized to body weight, but it may be also normalized to a distinct property of the biological target, such as tissue mass, surface area, or volume. In spite of its limitations, this initial dose is most often used to correlate with the biological effects in a toxicology study, and to perform extrapolation calculations (Jarabek et al., 2005) .
The biological activity of an inhaled particle can be influenced by the exposure modality (e.g. nose only vs. whole body), the aerosol characteristics (e.g. chemistry, size, and shape), the sites of deposition in the respiratory tract, the animal species, and even specific strains under study. In turn, aerosol deposition in different regions of the respiratory tract depends on particle characteristics, lung morphology, tidal volume, and breathing rate. For the purpose of this paper we will provide an overview of several anatomical and physiological factors that affect aerosol doses in mouse models. In addition, we will briefly review the dosimetric mathematical models that are currently available for the mouse.
Aerosol deposition phenomena
Inhaled particles will deposit in the respiratory tract if they move out of the air streams to come in contact with an airway surface. Although many mechanisms influence particle deposition, three main mechanisms that are usually included in mathematical dosimetry models are: inertial impaction; gravitational sedimentation; and Brownian diffusion (ICRP, 1994; NCRP, 1997; Brown et al., 2005) . These deposition mechanisms are independent of the animal species, but their relative importance is not. The deposition efficiency of particles in the different subregions of the respiratory tract (e.g. extrathoracic (ET), tracheobronchial (TB), and pulmonary (P)) will be dependent on the aerosol characteristics, delivery system used, breathing patterns, and airway morphology. The probability of particle deposition due to impaction is a function of the local airflow velocity, airway geometry, and particle inertia. Inertial impaction is an efficient deposition mechanism in areas with sharp transitions, as occur in the nasal turbinates, larynx, and at airway bifurcations. The probability for particle deposition due to sedimentation is proportional to residence time in the airways, particle size and density, and inversely proportional to breathing frequency. The probability for particles smaller than about 0.2 µm in diameter to deposit in the respiratory tract due to diffusion is proportional to residence time in the airways and is greater in areas of low airflow velocity and areas with turbulent flow (Housiadas and Lazaridis, 2010) . Even minor anatomical differences, as occur in strains within species, have the potential to significantly alter the total and local deposition efficiencies of inhaled aerosol particles.
Respiratory tract physiology
Physiological factors including breathing patterns and clearance mechanisms influence total and regional sites of particle doses. Among the breathing pattern phenomena that influence inhaled particle deposition are frequency, tidal volume, and minute ventilation. The more air that is inspired per unit time will directly increase the initial inhaled particle dose. Small animals, such as mice, inhale greater volumes of air normalized to body mass than their larger counterparts. The tidal volume and dead space volume affect deposition by influencing the depth of penetration of inspired air. The respiratory frequency and the duration of respiratory pauses will influence particle deposition due to sedimentation and diffusion mechanisms by affecting particle residence time in the respiratory tract. In addition, inspiratory and expiratory airflow rates will influence particle deposition efficiency throughout the respiratory tract. It is important to note that differences in breathing parameters among mouse strains and varieties have been widely reported in the literature (Tankersley et al., 1994 (Tankersley et al., , 1997 Han and Strohl; Flandre et al., 2003) . Table 1 shows respiratory frequencies (f), tidal volumes (V t ), and respiratory minute ventilation in several mouse strains. Particle clearance within the respiratory tract is dependent on the site of particle deposition. Particle clearance rates and mucociliary transport velocities in the upper respiratory tract (URT) and trachea have been reported for the mouse (Snipes et al., 1983; Brownstein, 1987; Hsieh et al., 1999; Foster et al., 2001; Grubb et al., 2004) . Physiological factors in the mouse have been shown to be dependent on many factors, including strain, gender, age, and disease status. In addition, transgenic mice can be designed to alter specific physiological factors that might modify the inhaled, deposited, and retained doses of particles in the respiratory tract (Grubb et al., 2004; Mall, 2008) . 
Respiratory tract anatomy
The mammalian respiratory tract can be divided in three main regions: ET, TB, and P). The airway anatomy in these regions is dependent on many factors, including species, strain, body size, frequently gender, and others. Anatomical features in each region can differ significantly among mouse strains and varieties. The respiratory tract geometry affects particle deposition in many ways. For example, airway diameter sets the maximum transverse displacement required for an airborne particle to contact a surface, while the cross-sectional area determines the airflow velocity and type of flow (i.e. laminar, turbulent, or mixed) for a given inspiratory flow rate. Therefore, the quantitative morphometric data available for the mouse respiratory tract will be briefly addressed.
ET region
The ET region, also known as the head airways or URT, extends from the nares down to the entrance of the trachea. The ET region includes the mouth, nasal cavity, pharynx, and larynx. The main mechanisms of particle deposition in the ET region are impaction and diffusion. Enhanced particle deposition in the URT occurs in areas characterized by obstructions (e.g. turbinates), constrictions (e.g. larynx), directional changes (e.g. pharyngeal bend), and high air velocities (e.g. nasal and laryngeal cavities). Although a complete anatomical model of the ET region of the mouse is not available, limited quantitative morphometric data have been reported and/or estimated for different areas of the URT (Gross et al., 1982; Andersen et al., 2000) , as shown in Table 2 .
The nasal cavity of mice is structurally complex and is the primary site of entry of inhaled air in the respiratory tract, as oral inhalation has not been seen to occur naturally. The nasal airways are divided into two passages by the nasal septum with each passage extending from the nostrils to the nasopharynx. The shape and complexity of the nasal turbinates is important factor in the filtration of inhaled aerosols by the ET region. Other factors influencing particle deposition in the nasal airways include the high volume of airflow through the ventral aspect of the nasal cavity over the nasal and maxillary turbinates and the pressure drop generated by the nasal region (Harkema et al., 2006) . Gross et al. (1982) determined the nasal cavity length, and the total surface area and volume for the B6C3F1 mouse (Table 2) . Additional quantitative data on the mouse nasal cavity in Table 2 have been taken from other independent studies (e.g. Andersen et al., 2000) .
The nasal pharynx is defined as the airway posterior to the termination of the soft palate, where the two air streams exiting the nasal cavity merge before entering the larynx and the TB region. The cross-sectional area of the nasal pharynx and its bend angle are important parameters that will affect particle deposition in this area. Limited quantitative data is available for the pharyngeal region of the New Zealand white mouse (Brennick et al., 2009 ). These investigators found that the dynamic cross-sectional area of the pharyngeal airways of an obese mouse model is significantly smaller than the lean counterpart, which can influence particle deposition in this area and have repercussions for subsequent particle deposition in the larynx, TB, and P region.
The larynx is a bilaterally symmetric organ characterized by its geometrically complex and variable protuberances, pouches, and folds. Its geometry varies with airflow and phonation. The laryngeal airway is a region of airflow acceleration (due to its constriction) that connects the URT to the TB region. The so-called "laryngeal jet" may enhance particle deposition in the trachea. Although detailed histological and anatomical descriptions of the mouse larynx are available in the literature, there is a lack of quantitative morphometric data that can be used to predict particle deposition in this area (Thomas et al., 2009 ).
TB region
The mammalian TB tree, which includes the trachea down to the terminal bronchioles can be subdivided into the bronchial region, which includes the trachea and main bronchi, and the bronchiolar region which consists of bronchioles and terminal bronchioles (Newton, 1995) . The main mechanisms of particle deposition in the TB region are impaction, sedimentation, and diffusion. Therefore, the branching mode and detailed features of airway geometry are important factors influencing the mechanisms and sites of particle deposition in the TB region. Branching angles determine changes in airflow direction at bifurcations, and thus affect particle deposition due to impaction, while the inclination angles relative to gravity affect particle sedimentation mechanisms. Linear dimensions such as the airway length and diameter, along with the number of airway units, at a given branching generation determine the volume and cross-sectional area, which strongly influences the airflow velocity, and establishes the type of flow regimen in the TB airways (e.g. laminar, turbulent, or mixed).
Quantitative morphometric analysis of the mouse TB airway geometry for two mouse strains, the B6C3F1 and the Balb/c, are available in the literature (Oldham et al., 1994; Oldham and Robinson, 2007) . Detailed measurements of replica mouse lung casts have provided data for typicallength pathways, airway lengths and diameters, as well as branching and gravity inclination angles (Table 3) . Oldham and Robinson (2007) reported a typical-length pathway of 15 generations for the Balb/c mouse. However the number of airway generations from trachea to terminal bronchioles can range from 6 to 27, which will have an effect on the intraand inter-lobar distribution of deposited particles. Significant differences in airway linear dimensions and cross-sectional areas for the two mouse strains are mainly observed in the bronchial region ( Figure 1A, 1B, 1C ). These differences have a dramatic effect on the TB tree volume ( Figure 1D ). It is predicted that these strain variations in the TB tree geometry will result in different inhaled doses and possibly different biological outcomes (Moss and Oldham, 2006) .
Pulmonary region
The P region of the mouse consists of the alveolar ducts and sacs, as mice lack respiratory bronchioles (Phalen, 2009 ). The main mechanisms of particle deposition in the P region are sedimentation and diffusion. The number of alveoli and alveolar surface area for the mouse is available in the literature (Mercer et al., 1994; Knust et al., 2009) . Quantitative morphometric data for the alveolar size have been reported for different mouse strains as shown in Table 4 . Quantitative data 
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for the branching structure beyond the terminal bronchiole has been estimated using the assumptions for rats of Yeh et al. (1979) ; for two mouse strains (Oldham et al., 1994; Oldham and Robinson, 2007) . Differences in alveolar size among inbred mouse strain and for mouse models of lung disease have also been reported (Soutiere et al., 2004; Parameswaran et al., 2009 ). These structural differences may affect particle deposition due to factors such as variations on the distance between the aerosols and alveolar walls, residence times, and airflow patterns.
Experimental and predicted particle deposition
Experimental nose-only inhalation data The most complete data to date on total and regional particle deposition in the mouse lung is that published by Raabe et al. (1988) (Table 5 ). In addition to Raabe's data, other groups have reported deposition fractions for additional (both smaller and larger) particle sizes (Alessandrini et al.; 2008 , Thomas et al., 2008 . Alessandrini et al. (2008) exposed Balb/c female mice to iridium labeled particles of 35 nm count median diameter and reported a total deposited fraction of 34% with 1% depositing in the ET airways. Of the total respiratory tract deposition, 40% was reported for the combined ET and TB airways, and of 60% for the alveolar region. Thomas et al. (2008) exposed female Balb/c mice to 12.4 µm aerosols, using a large-droplet aerosol generator, containing ∼7 microspheres (each 1.1 µm in diameter) per droplet. In this study, the reported deposition fractions were 36.5% in the URT, 0.64% in the trachea, and 1.4% in the deeper region of the lungs.
Mathematical models
Any dosimetry model should first consider the aerosol particle inhalability, which for nasal inhalation, is the sampling efficiency at the entrance of the nares. Although little is known about the inhalability of particles in the mouse, a logistic function for particle inhalability in small laboratory animals have been described based on Raabe's combined data for the mouse, rat, guinea pig, and hamster (Ménache et al., 1995) . Inhalability for particles with aerodynamic or physical diameters of about 0.7 µm or less is taken to be >95%; 55% for 7 µm particles; and <45% for 10 µm particles. However these values should only be used with caution in murine dosimetry, as they might be lower for the mouse.
Semi-empirical mathematical models have been established to predict nasal deposition efficiency in the mouse (Phalen and Oldham, 1991; Oldham et al., 1994; US EPA, 1994; Nadithe et al., 2003) . These models have been fitted to Raabe's data and mainly predict particle deposition due to impaction as a function of either flow rate or pressure drop. Figure 2 shows the predicted particle deposition for particles with aerodynamic diameters of 0.3-10 µm. However, experimental data is needed to confirm and/ or validate these model predictions. Mechanistic models, based on the whole-lung typical pathway reported by Oldham et al. (1994) and Oldham and Robinson (2007) for the B6C3F1 and the Balb/c mouse, have been described to predict particle deposition in the TB region. Since the lung casts used to provide TB morphometry data were assumed to be made at a total lung capacity, Hsieh et al. (1999) and Nadithe et al. (2003) adjusted the values to a functional residual capacity of 0.84 ml. Experimental data appears to agree with model-predicted values of particle deposition in the TB region of mice (Nadithe et al., 2003; Oldham et al., 2009 ). Mathematical models predicting particle deposition efficiency in the P region are perhaps limited because of the use of unproven assumptions to extrapolate anatomical data for this region (Hsieh et al., 1999; Nadithe et al., 2003; Oldham and Robinson, 2007) . Although morphometric data have been reported for alveolar surface area, size and volume, it has not been incorporated in these models. 
Conclusions
Although much is known about the variations in respiratory tract anatomy and physiology among mouse strains and varieties, the data are only beginning to elucidate the differences in inhaled particle doses. Additional morphometric information on all of the regions of the respiratory tract is needed before doses in inhalation studies can be predicted. In the meantime, actual deposition determinations should be made in studies as they are performed.
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